R&G PharmaStudies Co., Ltd. (SHE:301333)
China · Delayed Price · Currency is CNY 50.70
+3.38 (7.14%)
At close: Aug 4, 2026
R&G PharmaStudies Employees
R&G PharmaStudies had 2,645 employees as of December 31, 2025. The number of employees increased by 437 or 19.79% compared to the previous year.
Employees
2,645
Change (1Y)
437
Growth (1Y)
19.79%
Revenue / Employee
338.85K CNY
Profits / Employee
50.53K CNY
Market Cap
4.87B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,645 | 437 | 19.79% |
| Dec 31, 2024 | 2,208 | 166 | 8.13% |
| Dec 31, 2023 | 2,042 | 116 | 6.02% |
| Jan 1, 2023 | 1,926 | 1,298 | 206.69% |
| Dec 31, 2015 | 628 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Xiangxue Pharmaceutical | 2,662 |
| Anhui Huaheng Biotechnology | 2,252 |
| Novogene | 2,225 |
| ChemPartner PharmaTech | 1,771 |
| PharmaResources (Shanghai) | 1,155 |
| Wuhan Hvsen Biotechnology | 1,133 |
| Shenzhen Weiguang Biological Products | 901 |
| Beijing Konruns Pharmaceutical | 793 |